Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Gudrun C. Thurner"'
Autor:
Cornelia Speth, Ruben Bellotti, Georg Schäfer, Günter Rambach, Bernhard Texler, Gudrun C. Thurner, Dietmar Öfner, Cornelia Lass-Flörl, Manuel Maglione
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9833-9854 (2022)
Pancreatic ductal adenocarcinoma (PDAC) is still hampered by a dismal prognosis. A better understanding of the tumor microenvironment within the pancreas and of the factors affecting its composition is of utmost importance for developing new diagnost
Externí odkaz:
https://doaj.org/article/602fdd3901064a16b7ded8b62bd0bd00
Autor:
Paul Debbage, Gudrun C. Thurner
Publikováno v:
Pharmaceuticals, Vol 3, Iss 11, Pp 3371-3416 (2010)
Targeted nanoparticles have the potential to improve drug delivery efficiencies by more than two orders of magnitude, from the ~ 0.1% which is common today. Most pharmacologically agents on the market today are small drug molecules, which diffuse acr
Externí odkaz:
https://doaj.org/article/791a68190f7a4ea48bac8330f0940f19
Autor:
Anna Helbok, Werner Jaschke, Christian Kremser, Klammsteiner N, Paul Debbage, Maria M Stollenwerk, K Albrecht-Schgoer, E. A. Wallnöfer, Gudrun C. Thurner, Heribert Talasz, Hermann Dietrich
Publikováno v:
Histochemistry and cell biology. 155(1)
This multidisciplinary study examined the pharmacokinetics of nanoparticles based on albumin-DTPA-gadolinium chelates, testing the hypothesis that these nanoparticles create a stronger vessel signal than conventional gadolinium-based contrast agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62b40337033249ff1d866468aef6c956
https://pubmed.ncbi.nlm.nih.gov/33040183
https://pubmed.ncbi.nlm.nih.gov/33040183
Autor:
Gudrun C. Thurner, Paul Debbage
Publikováno v:
Histochemistry and Cell Biology
We explore present-day trends and challenges in nanomedicine. Creativity in the laboratories continues: the published literature on novel nanoparticles is now vast. Nanoagents are discussed here which are composed entirely of strongly photoluminescen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c677a5a852aec75dac032a1602de17d2
http://europepmc.org/articles/PMC6267421
http://europepmc.org/articles/PMC6267421
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 8932, p 8932 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 8932, p 8932 (2021)
Nanoparticles bearing specific targeting groups can, in principle, accumulate exclusively at lesion sites bearing target molecules, and release therapeutic agents there. However, practical application of targeted nanoparticles in the living organism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94604ae334d42ca2aa48c8b2b48aeb29
https://doi.org/10.3390/ijms22168932
https://doi.org/10.3390/ijms22168932
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 55:679-681
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb51699448fe3cc57440a5f1cc6a131
https://doi.org/10.5414/cpxces15ea02
https://doi.org/10.5414/cpxces15ea02
Autor:
Peter Lukas, Christoph Reinhold Arnold, Paul Debbage, Gudrun C. Thurner, Sergej Skvortsov, Ira-Ida Skvortsova, Alshaimaa Abdelmoez
Publikováno v:
Oncoscience
Metastatic progression of malignant tumors resistant to conventional therapeutic approaches is an ultimate challenge in clinical oncology. Despite the efforts of basic and clinical researchers, there is still no effective treatment schedule to preven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6645ea2d6b9629ee3b27cb5f2a5d5dd4
https://doi.org/10.18632/oncoscience.74
https://doi.org/10.18632/oncoscience.74
Autor:
Anna Helbok, Christine Rangger, Fritz Andreae, Elisabeth von Guggenberg, Matthias Saba-Lepek, Thorsten Radolf, Gudrun C. Thurner, Ruth Prassl, Clemens Decristoforo
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 8:112-118
Radiolabeled PEGylated liposomal nanoparticles (NPs) open new possibilities for a variety of applications including diagnosis, drug delivery, targeted therapy, and monitoring treatment effects. Here we describe the characterization of liposomal NPs (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0055393e7934f56ceb9dd04f2806888d
https://doi.org/10.1016/j.nano.2011.04.012
https://doi.org/10.1016/j.nano.2011.04.012
Autor:
Paul Debbage, Gudrun C. Thurner
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 50:55-64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95353d5dfa9811e0c6ac724205d4899f
https://doi.org/10.5414/cpp50055
https://doi.org/10.5414/cpp50055